G

Galectin Therapeutics
D

GALT

5.73500
USD
-0.57
(-8.97%)
مغلق
حجم التداول
36,507
الربح لكل سهم
-0
العائد الربحي
-
P/E
-9
حجم السوق
369,751,462
أصول ذات صلة الأخبار المقالات
المزيد

العنوان: Galectin Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.